The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Procept BioRobotics Corp shares valued at $26,249,951 were sold by Zadno Reza on Oct 30 ’24. At $91.00 per share, Zadno Reza sold 288,461 shares. The insider’s holdings dropped to 258,445 shares worth approximately $23.26 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Waters Kevin sold 25,000 shares, netting a total of over 1,811,653 in proceeds. Following the sale of shares at $72.47 each, the insider now holds 96,096 shares.
Before that, Waters Kevin had sold 25,000 shares from its account. In a trade valued at $2,062,679, the EVP, CFO traded Procept BioRobotics Corp shares for $82.51 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $8.65 million.
As published in their initiating research note from Piper Sandler on August 11, 2023, Procept BioRobotics Corp [PRCT] has been an Overweight and the price target has been revised to $42. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in late May. As of October 31, 2022, BTIG Research has initiated its “Neutral” rating for PRCT. Earlier on October 25, 2022, Truist initiated its rating. Their recommendation was “a Buy” for PRCT stock.
Analyzing PRCT Stock Performance
During the last five days, there has been a surge of approximately 34.67%. Over the course of the year, Procept BioRobotics Corp shares have jumped approximately 114.75%. Shares of the company reached a 52-week high of $99.34 on 10/30/24 and a 52-week low of $39.48 on 01/05/24. A 50-day SMA is recorded $77.42, while a 200-day SMA reached $62.17. Nevertheless, trading volume fell to 1.53 million shares from 2.04 million shares the previous day.
Support And Resistance Levels for Procept BioRobotics Corp (PRCT)
According to the 24-hour chart, there is a support level at 86.51, which, if violated, would cause prices to drop to 83.02. In the upper region, resistance lies at 93.48. The next price resistance is at 96.96. RSI (Relative Strength Index) is 65.82 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 17.13, which suggests the price will increase in the coming days. Percent R is at 28.48%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
